VERU
Price:
$0.8482
Market Cap:
$124.16M
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N. agencies, nonprofit organizations, and commercial partners. The company's development drug candidates include Enobosarm, an oral selective androgen receptor agonist that is in phase III clinical trial for the treatment of AR+ ER+ HER2- metastatic breast cancer; Sabizabulin, which is phase IIb clinical trial for the treatment of AR+ ER+ HER2- metastat...[Read more]
Industry
Biotechnology
IPO Date
1999-02-11
Stock Exchange
NASDAQ
Ticker
VERU
According to Veru Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.83. This represents a change of 31.81% compared to the average of -2.15 of the last 4 quarters.
The mean historical PE Ratio of Veru Inc. over the last ten years is 19.17. The current -2.83 PE Ratio has changed -1576.17% with respect to the historical average. Over the past ten years (40 quarters), VERU's PE Ratio was at its highest in in the March 2016 quarter at 382.23. The PE Ratio was at its lowest in in the March 2021 quarter at -71.19.
Average
19.17
Median
-1.80
Minimum
-13.79
Maximum
101.45
Discovering the peaks and valleys of Veru Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 878.05%
Maximum Annual PE Ratio = 101.45
Minimum Annual Increase = -1054.53%
Minimum Annual PE Ratio = -13.79
Year | PE Ratio | Change |
---|---|---|
2023 | -0.66 | -94.04% |
2022 | -11.02 | -112.52% |
2021 | 87.99 | -1054.53% |
2020 | -9.22 | -19.01% |
2019 | -11.38 | 286.14% |
2018 | -2.95 | -78.63% |
2017 | -13.79 | -113.59% |
2016 | 101.45 | 878.05% |
2015 | 10.37 | -74.65% |
2014 | 40.91 | 109.73% |
The current PE Ratio of Veru Inc. (VERU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
25.44
5-year avg
11.14
10-year avg
19.17
Veru Inc.’s PE Ratio is less than Seres Therapeutics, Inc. (-0.89), greater than Protalix BioTherapeutics, Inc. (-4.99), less than Lexicon Pharmaceuticals, Inc. (-2.49), greater than Iovance Biotherapeutics, Inc. (-6.48), greater than ImmunoGen, Inc. (-122.93), less than 2seventy bio, Inc. (-1.47), greater than Intercept Pharmaceuticals, Inc. (-13.55), less than Puma Biotechnology, Inc. (12.46), less than Sarepta Therapeutics, Inc. (257.91), greater than Anavex Life Sciences Corp. (-10.48), less than Annovis Bio, Inc. (-2.07), greater than Axsome Therapeutics, Inc. (-14.37), greater than Novavax, Inc. (-5.86),
Company | PE Ratio | Market cap |
---|---|---|
-0.89 | $145.36M | |
-4.99 | $73.54M | |
-2.49 | $582.00M | |
-6.48 | $3.04B | |
-122.93 | $8.73B | |
-1.47 | $226.59M | |
-13.55 | $794.69M | |
12.46 | $110.36M | |
257.91 | $12.29B | |
-10.48 | $436.70M | |
-2.07 | $102.73M | |
-14.37 | $4.47B | |
-5.86 | $1.86B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Veru Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Veru Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Veru Inc.'s PE Ratio?
How is the PE Ratio calculated for Veru Inc. (VERU)?
What is the highest PE Ratio for Veru Inc. (VERU)?
What is the 3-year average PE Ratio for Veru Inc. (VERU)?
What is the 5-year average PE Ratio for Veru Inc. (VERU)?
How does the current PE Ratio for Veru Inc. (VERU) compare to its historical average?